Chorda Pharma was founded to address the increasing prevalence of chronic pain conditions such as arthritis, diabetic neuropathy, and sports injuries. The company's core mission is to provide safe and effective pain relief without the use of opioids. Chorda Pharma's primary product is Capsadyn™, an over-the-counter topical cream designed to manage chronic pain. The company focuses on developing a pipeline of proprietary analgesics to offer long-term pain management solutions.
Notable affiliated individuals and investors include experts in pharmaceutical development and healthcare innovation, though specific names are not provided. Chorda Pharma's key achievements include the successful development and market introduction of Capsadyn™, which has been well-received for its efficacy and safety profile. The company's impact lies in its contribution to the opioid-free pain management market, providing millions of patients with safer alternatives for chronic pain relief.
